3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Ovarian Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
463
Cisplatin
379
Paclitaxel
313
Pemetrexed
300
Docetaxel
242
Erlotinib Hydrochloride
240
Gemcitabine
232
pembrolizumab
173
Radiotherapy
172
Bevacizumab
169
Nivolumab
130
Etoposide
106
Gefitinib
95
Vinorelbine
84
durvalumab
71
atezolizumab
68
Cetuximab
65
Topotecan
61
Drug Therapy
57
Ipilimumab
55
Irinotecan
54
osimertinib
53
Radiosurgery
52
Afatinib
51
Surveys and Questionnaires
38
130-nm albumin-bound paclitaxel
38
Albumin-Bound Paclitaxel
37
Taxes
35
Cyclophosphamide
35
Surgical Procedures, Operative
34
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Dried Blood Spot Testing
×
Thoracic
×
Clear all
NCT04154163
2022-02-28
ADOPT
University of Dundee
Completed
18 enrolled